These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

592 related articles for article (PubMed ID: 35074728)

  • 21. Anti-SARS-CoV-2 Vaccines and Monoclonal Antibodies Facing Viral Variants.
    Chaqroun A; Hartard C; Schvoerer E
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34207378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A review: Antibody-dependent enhancement in COVID-19: The not so friendly side of antibodies.
    Sánchez-Zuno GA; Matuz-Flores MG; González-Estevez G; Nicoletti F; Turrubiates-Hernández FJ; Mangano K; Muñoz-Valle JF
    Int J Immunopathol Pharmacol; 2021; 35():20587384211050199. PubMed ID: 34632844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sex Differences in Lung Imaging and SARS-CoV-2 Antibody Responses in a COVID-19 Golden Syrian Hamster Model.
    Dhakal S; Ruiz-Bedoya CA; Zhou R; Creisher PS; Villano JS; Littlefield K; Ruelas Castillo J; Marinho P; Jedlicka AE; Ordonez AA; Bahr M; Majewska N; Betenbaugh MJ; Flavahan K; Mueller ARL; Looney MM; Quijada D; Mota F; Beck SE; Brockhurst J; Braxton AM; Castell N; Stover M; D'Alessio FR; Metcalf Pate KA; Karakousis PC; Mankowski JL; Pekosz A; Jain SK; Klein SL;
    mBio; 2021 Aug; 12(4):e0097421. PubMed ID: 34253053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Immunopathobiology of SARS-CoV-2 Infection.
    Patel M; Shahjin F; Cohen JD; Hasan M; Machhi J; Chugh H; Singh S; Das S; Kulkarni TA; Herskovitz J; Meigs DD; Chandra R; Hettie KS; Mosley RL; Kevadiya BD; Gendelman HE
    FEMS Microbiol Rev; 2021 Nov; 45(6):. PubMed ID: 34160586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mapping SARS-CoV-2 Antibody Epitopes in COVID-19 Patients with a Multi-Coronavirus Protein Microarray.
    Camerini D; Randall AZ; Trappl-Kimmons K; Oberai A; Hung C; Edgar J; Shandling A; Huynh V; Teng AA; Hermanson G; Pablo JV; Stumpf MM; Lester SN; Harcourt J; Tamin A; Rasheed M; Thornburg NJ; Satheshkumar PS; Liang X; Kennedy RB; Yee A; Townsend M; Campo JJ
    Microbiol Spectr; 2021 Oct; 9(2):e0141621. PubMed ID: 34704808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlates of Neutralization against SARS-CoV-2 Variants of Concern by Early Pandemic Sera.
    Vidal SJ; Collier AY; Yu J; McMahan K; Tostanoski LH; Ventura JD; Aid M; Peter L; Jacob-Dolan C; Anioke T; Chang A; Wan H; Aguayo R; Ngo D; Gerszten RE; Seaman MS; Barouch DH
    J Virol; 2021 Jun; 95(14):e0040421. PubMed ID: 33893169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RIG-I-Like Receptor-Mediated Recognition of Viral Genomic RNA of Severe Acute Respiratory Syndrome Coronavirus-2 and Viral Escape From the Host Innate Immune Responses.
    Kouwaki T; Nishimura T; Wang G; Oshiumi H
    Front Immunol; 2021; 12():700926. PubMed ID: 34249006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Will Mutations in the Spike Protein of SARS-CoV-2 Lead to the Failure of COVID-19 Vaccines?
    Jia Z; Gong W
    J Korean Med Sci; 2021 May; 36(18):e124. PubMed ID: 33975397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human Nasal and Lung Tissues Infected
    Alfi O; Yakirevitch A; Wald O; Wandel O; Izhar U; Oiknine-Djian E; Nevo Y; Elgavish S; Dagan E; Madgar O; Feinmesser G; Pikarsky E; Bronstein M; Vorontsov O; Jonas W; Ives J; Walter J; Zakay-Rones Z; Oberbaum M; Panet A; Wolf DG
    J Virol; 2021 Jun; 95(14):e0013021. PubMed ID: 33893170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evolutionary trajectory of SARS-CoV-2 and emerging variants.
    Singh J; Pandit P; McArthur AG; Banerjee A; Mossman K
    Virol J; 2021 Aug; 18(1):166. PubMed ID: 34389034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19.
    Gusev E; Sarapultsev A; Solomatina L; Chereshnev V
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Daily Viral Kinetics and Innate and Adaptive Immune Response Assessment in COVID-19: a Case Series.
    Vetter P; Eberhardt CS; Meyer B; Martinez Murillo PA; Torriani G; Pigny F; Lemeille S; Cordey S; Laubscher F; Vu DL; Calame A; Schibler M; Jacquerioz F; Blanchard-Rohner G; Siegrist CA; Kaiser L; Didierlaurent AM; Eckerle I
    mSphere; 2020 Nov; 5(6):. PubMed ID: 33177214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An update on host immunity correlates and prospects of re-infection in COVID-19.
    Negi N; Maurya SP; Singh R; Das BK
    Int Rev Immunol; 2022; 41(4):367-392. PubMed ID: 34961403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on haemodialysis.
    Strengert M; Becker M; Ramos GM; Dulovic A; Gruber J; Juengling J; Lürken K; Beigel A; Wrenger E; Lonnemann G; Cossmann A; Stankov MV; Dopfer-Jablonka A; Kaiser PD; Traenkle B; Rothbauer U; Krause G; Schneiderhan-Marra N; Behrens GMN
    EBioMedicine; 2021 Aug; 70():103524. PubMed ID: 34391096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Observations and Perspectives on Adaptive Immunity to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
    Dan J; da Silva Antunes R; Grifoni A; Weiskopf D; Crotty S; Sette A
    Clin Infect Dis; 2022 Aug; 75(Suppl 1):S24-S29. PubMed ID: 35441229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of HLA-A*24:02-Restricted CTL Candidate Epitopes Derived from the Nonstructural Polyprotein 1a of SARS-CoV-2 and Analysis of Their Conservation Using the Mutation Database of SARS-CoV-2 Variants.
    Takagi A; Matsui M
    Microbiol Spectr; 2021 Dec; 9(3):e0165921. PubMed ID: 34937174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emerging SARS-CoV-2 variants: impact on vaccine efficacy and neutralizing antibodies.
    Sharun K; Tiwari R; Dhama K; Emran TB; Rabaan AA; Al Mutair A
    Hum Vaccin Immunother; 2021 Oct; 17(10):3491-3494. PubMed ID: 34161189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of micronutrient and immunomodulation effect in the vaccine era of COVID-19.
    Lai YJ; Chang HS; Yang YP; Lin TW; Lai WY; Lin YY; Chang CC
    J Chin Med Assoc; 2021 Sep; 84(9):821-826. PubMed ID: 34282078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Interaction between SARS-CoV-2 and Host Innate Immunity].
    Duan XQ; Xie H; Chen LM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Jan; 53(1):1-6. PubMed ID: 35048592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Innate and Adaptive Immune Responses in the Upper Respiratory Tract and the Infectivity of SARS-CoV-2.
    Ramasamy R
    Viruses; 2022 Apr; 14(5):. PubMed ID: 35632675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.